CO5271679A1 - Inhibidores de proteasa 7-14 miembros - Google Patents
Inhibidores de proteasa 7-14 miembrosInfo
- Publication number
- CO5271679A1 CO5271679A1 CO00011383A CO00011383A CO5271679A1 CO 5271679 A1 CO5271679 A1 CO 5271679A1 CO 00011383 A CO00011383 A CO 00011383A CO 00011383 A CO00011383 A CO 00011383A CO 5271679 A1 CO5271679 A1 CO 5271679A1
- Authority
- CO
- Colombia
- Prior art keywords
- alkyl
- het
- group
- nr2h
- cycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/16—Eight-membered rings
- C07D313/18—Eight-membered rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12069999P | 1999-02-19 | 1999-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5271679A1 true CO5271679A1 (es) | 2003-04-30 |
Family
ID=22392011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00011383A CO5271679A1 (es) | 1999-02-19 | 2000-02-18 | Inhibidores de proteasa 7-14 miembros |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1153022A4 (fr) |
| JP (1) | JP2002537297A (fr) |
| AU (1) | AU3235100A (fr) |
| CO (1) | CO5271679A1 (fr) |
| DZ (1) | DZ3083A1 (fr) |
| HK (1) | HK1042695A1 (fr) |
| PE (1) | PE20001486A1 (fr) |
| WO (1) | WO2000049011A1 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7168084B1 (en) | 1992-12-09 | 2007-01-23 | Sedna Patent Services, Llc | Method and apparatus for targeting virtual objects |
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| EP1232155A4 (fr) | 1999-11-10 | 2002-11-20 | Smithkline Beecham Corp | Inhibiteurs de protease |
| WO2001034600A1 (fr) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Inhibiteurs de protease |
| JP2003513924A (ja) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | プロテア−ゼ阻害剤 |
| SK13632002A3 (sk) | 2000-03-21 | 2003-02-04 | Smithkline Beecham Corporation | C1-6-alkyl-4-amino-azepán-3-ónové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukty |
| DE60118793T2 (de) * | 2000-11-17 | 2007-04-26 | Medivir Ab | Cystein protease inhibitoren |
| EP1345931A2 (fr) * | 2000-11-17 | 2003-09-24 | Medivir UK Ltd | Inhibiteurs de cysteine protease |
| EP1482020B1 (fr) * | 2003-05-27 | 2006-09-06 | MERCK PATENT GmbH | Dérivés de pyrane avec une double liaison exocyclique |
| DE102004021338A1 (de) | 2003-05-27 | 2005-03-03 | Merck Patent Gmbh | Pyranderivate |
| EP1757284A1 (fr) * | 2005-08-25 | 2007-02-28 | Santhera Pharmaceuticals (Schweiz) AG | Utilisation de la N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) pour la prévention ou le traitement de la dystrophie musculaire |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5021432A (en) * | 1988-04-26 | 1991-06-04 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzopyran compound and its pharmaceutical use |
| CA2157412A1 (fr) * | 1993-03-03 | 1994-09-15 | Julia Marie Heerding | Balanoides |
| US5612370A (en) * | 1995-06-07 | 1997-03-18 | Bristol-Myers Squibb Company | Phenylglycine and phenylalaninen amido benzopyran derivatives |
| AR013079A1 (es) * | 1997-05-06 | 2000-12-13 | Smithkline Beecham Corp | Derivados sustituidos de tetrahidrofurano-3-onas, de tetrahidropirano-3- onas y tetrahidrotiofen-3-onas, un procedimiento para su preparacion unacomposicion farmaceutica de un medicamento util como inhibidores de proteasas e intermediarios |
-
2000
- 2000-02-16 DZ DZ000030A patent/DZ3083A1/fr active
- 2000-02-17 JP JP2000599751A patent/JP2002537297A/ja not_active Withdrawn
- 2000-02-17 WO PCT/US2000/004133 patent/WO2000049011A1/fr not_active Application Discontinuation
- 2000-02-17 EP EP00910222A patent/EP1153022A4/fr not_active Withdrawn
- 2000-02-17 AU AU32351/00A patent/AU3235100A/en not_active Abandoned
- 2000-02-18 CO CO00011383A patent/CO5271679A1/es not_active Application Discontinuation
- 2000-02-18 PE PE2000000128A patent/PE20001486A1/es not_active Application Discontinuation
-
2002
- 2002-03-28 HK HK02102419.7A patent/HK1042695A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000049011A1 (fr) | 2000-08-24 |
| EP1153022A4 (fr) | 2002-03-27 |
| EP1153022A1 (fr) | 2001-11-14 |
| DZ3083A1 (fr) | 2004-06-02 |
| HK1042695A1 (zh) | 2002-08-23 |
| JP2002537297A (ja) | 2002-11-05 |
| AU3235100A (en) | 2000-09-04 |
| PE20001486A1 (es) | 2001-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5200785A1 (es) | Uso terapeutico de quinazolina | |
| AR240929A2 (es) | "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas" | |
| DE59308619D1 (de) | Germicide wirkstoffkombinationen | |
| CO5261616A1 (es) | Inhibidores no peptidicos de la union celular dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias | |
| CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
| NO20013379L (no) | 4-okso-1,4-dihydro-3-kinolinkarboksamider som antivirusmidler | |
| RU2009102832A (ru) | С-фенил-1-тилоглюцитолы | |
| CO5271679A1 (es) | Inhibidores de proteasa 7-14 miembros | |
| CO5251427A1 (es) | Oxazolidinonas que tienen la fucion de sulfoximina | |
| ATE300543T1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
| CO5080791A1 (es) | Derivados de la piperidina que tienen efectos sobre sistemas con serotonina | |
| DK1189900T3 (da) | Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler | |
| CO5261538A1 (es) | Nuevos acidos (aminopropil) metilfosfinicos | |
| CO5261527A1 (es) | Eteres del acido benzoico de oxazolidinonas que tienen un substituyente hidroxiacetilpiperazina | |
| DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
| ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| DK1202954T3 (da) | Nye aminobenzophenoner | |
| CO5200762A1 (es) | Preparacion de piperidin-4-onas sustituidas | |
| DK1204658T3 (da) | Benzofurylpiperazin-serotoninagonister | |
| DE60122559D1 (de) | Indolderivate als pde5-inhibitoren | |
| ATE293111T1 (de) | Kondensierte pyrazindionderivate als pde inhibitoren | |
| DE60121048D1 (de) | PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE | |
| CO5180541A1 (es) | Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros | |
| CO5180536A1 (es) | Inhibidores de proteasas catepsina | |
| CO5180542A1 (es) | Inhibidores de proteasas 1,3-dioxepin-5-ona con anillo de 7 miembros |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |